| Nutrition, Health and Food Behavior | Lifetime | 32 | KR 13 | 98.60 |
| Health and Wellbeing Research | Lifetime | 85 | KR 20 | 97.89 |
| Liver Disease Diagnosis and Treatment | Lifetime | 891 | KR 28 | 98.92 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 357 | KR 1 | 98.72 |
| Diabetes Treatment and Management | Lifetime | 396 | KR 3 | 98.51 |
| Oral microbiology and periodontitis research | Lifetime | 481 | KR 1 | 98.00 |
| Cancer, Lipids, and Metabolism | Lifetime | 828 | KR 8 | 97.13 |
| Metabolism, Diabetes, and Cancer | Lifetime | 784 | KR 7 | 97.30 |
| Nutrition and Health in Aging | Lifetime | 894 | KR 14 | 97.13 |
| Nutritional Studies and Diet | Lifetime | 734 | KR 3 | 97.68 |
| Alcohol Consumption and Health Effects | Lifetime | 446 | KR 5 | 96.88 |
| Dental Health and Care Utilization | Lifetime | 402 | KR 1 | 97.45 |
| Folate and B Vitamins Research | Lifetime | 773 | KR 6 | 95.23 |
| Cancer Risks and Factors | Lifetime | 516 | KR 5 | 96.51 |
| Menopause: Health Impacts and Treatments | Lifetime | 272 | KR 2 | 95.31 |
| Salivary Gland Disorders and Functions | Lifetime | 609 | KR 5 | 94.25 |
| Diabetes Management and Education | Lifetime | 758 | KR 11 | 93.78 |
| Oral Health Pathology and Treatment | Lifetime | 870 | KR 5 | 93.23 |
| Cardiovascular Health and Risk Factors | Lifetime | 877 | KR 6 | 90.31 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 687 | KR 6 | 88.36 |
| Menstrual Health and Disorders | Lifetime | 721 | KR 7 | 81.35 |
| Ginkgo biloba and Cashew Applications | Lifetime | 921 | KR 21 | 75.89 |
| Folate and B Vitamins Research | 2021-2025 | 3 | KR 1 | 98.63 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 56 | KR 1 | 99.63 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 15 | KR 1 | 99.51 |
| Alcohol Consumption and Health Effects | 2021-2025 | 13 | KR 1 | 99.11 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 27 | KR 1 | 99.07 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 42 | KR 1 | 98.75 |
| Cancer Risks and Factors | 2021-2025 | 23 | KR 1 | 97.95 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 45 | KR 1 | 97.32 |
| Chronic Disease Management Strategies | 2021-2025 | 47 | KR 1 | 97.85 |
| Nutritional Studies and Diet | 2021-2025 | 88 | KR 2 | 98.25 |
| Diabetes Treatment and Management | 2021-2025 | 87 | KR 1 | 99.03 |
| Diabetes Management and Education | 2021-2025 | 29 | KR 2 | 97.55 |
| Diet and metabolism studies | 2021-2025 | 182 | KR 2 | 97.80 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 116 | KR 1 | 98.16 |
| Bone health and osteoporosis research | 2021-2025 | 49 | KR 3 | 97.33 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 243 | KR 3 | 98.12 |
| Cardiac Health and Mental Health | 2021-2025 | 85 | KR 1 | 96.41 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 105 | KR 2 | 97.47 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 303 | KR 17 | 97.80 |
| Diabetes Management and Research | 2021-2025 | 162 | KR 2 | 97.69 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 17 | KR 2 | 95.12 |
| Nutrition and Health in Aging | 2021-2025 | 318 | KR 14 | 96.28 |
| Neurological and metabolic disorders | 2021-2025 | 17 | KR 1 | 92.20 |
| Diet, Metabolism, and Disease | 2021-2025 | 152 | KR 11 | 95.40 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 265 | KR 14 | 95.67 |
| Retinal Diseases and Treatments | 2021-2025 | 338 | KR 5 | 96.56 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 542 | KR 18 | 96.19 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 470 | KR 7 | 96.03 |
| Liver Disease and Transplantation | 2021-2025 | 418 | KR 21 | 95.88 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 158 | KR 5 | 91.18 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 898 | KR 48 | 94.45 |
| Retinal Imaging and Analysis | 2021-2025 | 375 | KR 8 | 94.34 |
| Hip and Femur Fractures | 2021-2025 | 289 | KR 15 | 93.08 |
| Bariatric Surgery and Outcomes | 2021-2025 | 227 | KR 2 | 93.60 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 101 | KR 4 | 89.49 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 298 | KR 11 | 93.28 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 756 | KR 23 | 94.35 |
| Ophthalmology and Eye Disorders | 2021-2025 | 147 | KR 16 | 90.52 |
| Renal and Vascular Pathologies | 2021-2025 | 251 | KR 7 | 89.44 |
| Estrogen and related hormone effects | 2021-2025 | 199 | KR 2 | 88.81 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 119 | KR 2 | 89.10 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 682 | KR 23 | 91.61 |
| Dysphagia Assessment and Management | 2021-2025 | 331 | KR 9 | 89.52 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 292 | KR 4 | 89.73 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 84 | KR 2 | 89.76 |
| Nutrition, Health and Food Behavior | 2021-2025 | 66 | KR 53 | 86.26 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 348 | KR 8 | 87.97 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 793 | KR 69 | 89.51 |
| Diabetic Foot Ulcer Assessment and Management | 2021-2025 | 394 | KR 6 | 87.88 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 238 | KR 7 | 84.65 |
| Inflammatory Bowel Disease | 2021-2025 | 990 | KR 26 | 89.95 |
| Obesity and Health Practices | 2021-2025 | 276 | KR 2 | 86.50 |
| Diabetes and associated disorders | 2021-2025 | 742 | KR 7 | 87.53 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 724 | KR 20 | 88.08 |
| Neurological Complications and Syndromes | 2021-2025 | 129 | KR 4 | 84.62 |
| Microscopic Colitis | 2021-2025 | 747 | KR 14 | 88.90 |
| Dermatology and Skin Diseases | 2021-2025 | 997 | KR 48 | 87.00 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 750 | KR 66 | 85.64 |
| Aortic aneurysm repair treatments | 2021-2025 | 880 | KR 3 | 85.79 |
| Smoking Behavior and Cessation | 2021-2025 | 593 | KR 12 | 86.15 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 945 | KR 93 | 83.60 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 438 | KR 11 | 82.56 |
| Obstructive Sleep Apnea Research | 2021-2025 | 982 | KR 25 | 83.11 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 865 | KR 9 | 81.91 |
| Diverse Approaches in Healthcare and Education Studies | 2021-2025 | 298 | KR 256 | 78.82 |
| Health and Wellbeing Research | 2021-2025 | 447 | KR 198 | 77.16 |
| Bone and Joint Diseases | 2021-2025 | 681 | KR 30 | 75.55 |
| Migraine and Headache Studies | 2021-2025 | 681 | KR 15 | 79.91 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 672 | KR 14 | 75.27 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 952 | KR 7 | 73.18 |
| Restless Legs Syndrome Research | 2021-2025 | 250 | KR 19 | 72.12 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 613 | KR 16 | 66.26 |
| Lipid metabolism and disorders | 2021-2025 | 644 | KR 15 | 67.03 |
| Neurological diseases and metabolism | 2021-2025 | 780 | KR 14 | 61.74 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 341 | KR 16 | 59.10 |
| Intraoperative Neuromonitoring and Anesthetic Effects | 2021-2025 | 480 | KR 16 | 44.24 |